The 15-minute test measures blood levels of C-reactive protein, a general marker of infection severity, and two other proteins that the immune system produces in response to viral infections.
The test beats accuracy rates of other COVID-19 severity tests, including the commonly used biomarker IL-6.
The research team developed the test via a data analysis from a group of 518 COVID-19 patients, 113 of whom had a severe outcome.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
